Been a while since we have had any clotology on here. That is unacceptable. So here we go with another journal club fest on the management of acute VTE. Now
The rise and SURPRISE of the DOACs. St.Emlyn’s Read More
Every so often, a paper comes along that contradicts your gut feeling and/or current practice and makes you really think hard. That happened to me this weekend. You may have
JC: Clots in Pots gets Top Spot. Thromboprophylaxis at St.Emlyn’s Read More
A familiar scenario: You are on duty and your standby phone goes off just as you have come back from your coffee break. The ambulance cell informs you that they
Nil nocere: do no harm reversing warfarin! Read More
You don’t need me to tell you that VTE is a huge problem. 10 million cases worldwide, a cost to the NHS of £466,000,000 and half a million European deaths
VTE masterclass with Dan Horner at #RCEM15 Read More
Virchester has a long history of research in the ambulatory management of venous thromboembolism. Several MDs and PhDs have been completed here looking at both therapeutic and diagnostic strategies in
JC: Do all VTE patients need a CT for cancer? Read More
Where would we be without warfarin? The good old rat poison has served us brilliantly for decades, allowing us to anticoagulate patients to treat and prevent venous thromboembolism, prevent stroke
Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1 Read More
A new study in the BMJ this week suggests benefit from use of the new oral anticoagulants. This is of significance to those of us in UK emergency medicine involved in
The new oral anticoagulants – the good news – or is it? Read More
So, we’ve already talked about this. But changing times call for changing posts. And we want to know what you think… A 30 year old comes in 10 days after
The POP, the Chief, his risk assessment and her thromboprophylaxis Read More
